WO2009009045A3 - Escape libraries of target polypeptides - Google Patents
Escape libraries of target polypeptides Download PDFInfo
- Publication number
- WO2009009045A3 WO2009009045A3 PCT/US2008/008367 US2008008367W WO2009009045A3 WO 2009009045 A3 WO2009009045 A3 WO 2009009045A3 US 2008008367 W US2008008367 W US 2008008367W WO 2009009045 A3 WO2009009045 A3 WO 2009009045A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- library
- escape
- target polypeptide
- identified
- variant polypeptides
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
- G01N33/6845—Methods of identifying protein-protein interactions in protein mixtures
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
- G01N2500/02—Screening involving studying the effect of compounds C on the interaction between interacting molecules A and B (e.g. A = enzyme and B = substrate for A, or A = receptor and B = ligand for the receptor)
Abstract
The present invention provides methods for identifying escape variants of a target polypeptide. The methods typically involve generating a library of variant polypeptides of the target polypeptide on a replicable display platform (e.g., phage display), identifying variant polypeptides which maintain the ability to bind to a known binding partner of the target polypeptide, and examining the identified variant polypeptides to identify escape variants whose binding to the binding partner is not antagonized by a library of known compounds which disrupt binding between the target polypeptide and the binding partner. The methods can further entail screening a library of candidate antagonist agents to identify a cognate antagonist agent which antagonizes binding between the escape variant and the binding partner. Additional escape variants can be identified by creating a library of further variant polypeptides of the identified escape variant, and subject the further variant polypeptides to the screening process. In each subsequent round of screening, the identified antagonist agent is combined with the library of known compounds employed in the previous round of screening. The invention also provides related methods for identifying novel antagonist agents of a target polypeptide. Further provided are vectors and kits for displaying a functional multimeric target protein on the surface of a phage.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US95892507P | 2007-07-10 | 2007-07-10 | |
US60/958,925 | 2007-07-10 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009009045A2 WO2009009045A2 (en) | 2009-01-15 |
WO2009009045A3 true WO2009009045A3 (en) | 2010-03-18 |
Family
ID=40229342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2008/008367 WO2009009045A2 (en) | 2007-07-10 | 2008-07-08 | Escape libraries of target polypeptides |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2009009045A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9347058B2 (en) | 2011-05-17 | 2016-05-24 | Bristol-Myers Squibb Company | Methods for the selection of binding proteins |
TW201418707A (en) * | 2012-09-21 | 2014-05-16 | Alexion Pharma Inc | Screening assays for complement component C5 antagonists |
AU2015336308B2 (en) * | 2014-10-20 | 2020-05-14 | The Scripps Research Institute | Proximity based methods for selection of binding partners |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571836A (en) * | 1992-11-09 | 1996-11-05 | Bovin; Nicolai V. | Viral attachment inhibitors |
US6277489B1 (en) * | 1998-12-04 | 2001-08-21 | The Regents Of The University Of California | Support for high performance affinity chromatography and other uses |
US20050136428A1 (en) * | 2003-06-27 | 2005-06-23 | Roberto Crea | Look-through mutagenesis |
US6943000B2 (en) * | 1997-10-03 | 2005-09-13 | University Of Massachusetts | JNK3 modulators and methods of use |
US20060084608A1 (en) * | 2000-08-18 | 2006-04-20 | Human Genome Sciences, Inc. | Binding polypeptides and methods based thereon |
US7135287B1 (en) * | 1999-10-02 | 2006-11-14 | Biosite, Inc. | Human antibodies |
-
2008
- 2008-07-08 WO PCT/US2008/008367 patent/WO2009009045A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5571836A (en) * | 1992-11-09 | 1996-11-05 | Bovin; Nicolai V. | Viral attachment inhibitors |
US6943000B2 (en) * | 1997-10-03 | 2005-09-13 | University Of Massachusetts | JNK3 modulators and methods of use |
US6277489B1 (en) * | 1998-12-04 | 2001-08-21 | The Regents Of The University Of California | Support for high performance affinity chromatography and other uses |
US7135287B1 (en) * | 1999-10-02 | 2006-11-14 | Biosite, Inc. | Human antibodies |
US20060084608A1 (en) * | 2000-08-18 | 2006-04-20 | Human Genome Sciences, Inc. | Binding polypeptides and methods based thereon |
US20050136428A1 (en) * | 2003-06-27 | 2005-06-23 | Roberto Crea | Look-through mutagenesis |
Also Published As
Publication number | Publication date |
---|---|
WO2009009045A2 (en) | 2009-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201991461A1 (en) | METHODS AND DEVICES FOR EVALUATING THE CONTENT OF MATERIALS | |
BR112015013515A2 (en) | methods of generating a mass-defined drug candidate library, and for identifying peptides having a pharmacological property | |
WO2009090553A3 (en) | Compositions and methods of detecting post-stop peptides | |
WO2009025846A3 (en) | Activatable binding polypeptides and methods of identification and use thereof | |
WO2009143519A3 (en) | Biomarkers for myocardial ischemia | |
DE602006018424D1 (en) | PEPTIDES FOR THE DETECTION OF EHRLICHIA EWINGII ANTIBODIES | |
WO2006094704A3 (en) | Natural ligand of g protein coupled receptor rcc356 and uses thereof | |
AU2016204135A1 (en) | Screening methods for transfusion related acute lung injury (TRALI) | |
WO2009009045A3 (en) | Escape libraries of target polypeptides | |
EP1733234A4 (en) | Methods of determining allergen response using microarray imminoassay techinques | |
BRPI0606685A2 (en) | gitr antibodies for diagnosis of nsclc | |
WO2012004631A3 (en) | Recombinant antibody structures binding to and blocking the activity of vascular endothelial growth factor 2 (vegfr- 2 /kdr) | |
Tetzner et al. | Decarboxylation of Ang-(1–7) to Ala1-Ang-(1–7) leads to significant changes in pharmacodynamics | |
PL2183599T3 (en) | High sensitivty immunoassays and kits for the determination of peptides and proteins of biological interest | |
WO2010059981A3 (en) | High complexity mammalian display library and methods of screening | |
WO2006087163A3 (en) | Novel in vitro methods for studying receptors recognizing volatile compounds | |
WO2006122053A3 (en) | Biomarkers for evaluating likelihood of tumor sensitivity to an mtor inhibitor | |
Park et al. | Isolation and characterization of a monobody with a fibronectin domain III scaffold that specifically binds EphA2 | |
Kapoerchan et al. | Design, synthesis and evaluation of high-affinity binders for the celiac disease associated HLA-DQ2 molecule | |
WO2009155366A3 (en) | Improved peptide mediators of cholesterol efflux | |
WO2008020192A3 (en) | Secretogranin and vgf peptide biomarkers and uses thereof | |
WO2007024877A3 (en) | Compositions and methods for analyzing protein interactions | |
Vilanova et al. | Art‐omics: multi‐omics meet archaeology and art conservation | |
JP2011004734A5 (en) | ||
TW200613250A (en) | Process for the preparation of amino acids useful in the preparation of peptide receptor modulators |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08780021 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 08780021 Country of ref document: EP Kind code of ref document: A2 |